Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

N3 induced reprogramming and ShWT1 knock-down in DSRCT cell lines

ABSTRACT: N3 induced reprogramming and ShWT1 knock-down in DSRCT cell lines

PROVIDER: PRJNA746313 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

N3 induced reprogramming and ShWT1 knock-down in DSRCT cell lines

Project description:The object of this study is to identify the molecular signature underlying the therapeutic potential of N3-induced growth arrest in Desmoplastic Small Round Cell Tumor (DSRCT). The molecular hallmark of DSRCT is the EWS-WT1 fusion protein formed by chromosomal translocations found in DSRCT. The N-terminal transactivation domain of EWS is fused to the C-terminal DNA binding domain of WT1, creating an oncogenic transcription factor. We have recently discovered that addition of N3 supplement to growing DSRCT cells leads to a rapid cessation of cell growth.

2022-04-14 | GSE180031 | GEO

SPARC knock down

Project description:SPARC knock down

| PRJNA327124 | ENA

FGFR3 knock-down

Project description:FGFR3 knock-down

| PRJNA330963 | ENA

CRISPR/Cas9 knock down line

Project description:CRISPR/Cas9 knock down line

| PRJNA521684 | ENA

Hyperoxia in FGF10 knock-down mice

Project description:Hyperoxia in FGF10 knock-down mice

| PRJNA306852 | ENA

Fgf10 knock-down effects in hyperoxia

Project description:Fgf10 knock-down effects in hyperoxia

| PRJNA450016 | ENA

Fgf10 knock-down effects in normoxia

Project description:Fgf10 knock-down effects in normoxia

| PRJNA450017 | ENA

Herbaspirillum hiltneri N3 strain:N3

Project description:Herbaspirillum hiltneri N3 strain:N3 Genome sequencing

| PRJNA182106 | ENA

MEF2C knock-down in Human Skeletal Myoblasts

Project description:MEF2C knock-down in Human Skeletal Myoblasts

| PRJNA525423 | ENA

RNA-Seq of Primary and Recurrent DSRCT Tumors

Project description:Desmoplastic small round cell tumor (DSRCT) is a rare pediatric cancer caused by the EWSR1-WT1 fusion oncogene. Despite initial response to chemotherapy, DSRCT has a recurrence rate of over 80% leading to poor patient prognosis with a 5-year survival rate of only 15-25%. Owing to the rarity of DSRCT, sample scarcity is a barrier to understanding DSRCT biology and developing effective therapies. Here, we performed RNA-sequencing on a novel pair of primary and recurrent DSRCT tumors harvested from the same patient 5-years apart. To gain insights into gene expression alterations associated with recurrence, we performed pathway analysis on Gene Ontology Biological Processes and KEGG pathways. Upregulated pathways in the recurrent tumor included DNA repair and mRNA splicing related pathways, while downregulated pathways included immune system function and focal adhesion. We further examined the expression of previously identified EWSR1-WT1 regulated targets, a large number of which were enriched in the recurrent tumor. Overall, this study provides novel understanding of DSRCT biology and a new RNA-seq data set to advance future studies.

2023-07-19 | GSE230603 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data